The American Association for Cancer Research (AACR) today announced its 11 newly elected Fellows of the AACR Academy, including Thomas R. Cech, PhD, investigator at the University of Colorado Cancer Center, distinguished professor of chemistry and biochemistry, and director, BioFrontiers Institute, University of Colorado at Boulder.
The AACR Academy serves to recognize and honor distinguished scientists whose major scientific contributions have propelled significant innovation and progress against cancer. All Fellows are nominated and elected through a rigorous peer-review process conducted by existing Fellows of the AACR Academy and ratified by the AACR Executive Committee. This process involves an assessment of each candidate on the basis of his or her scientific achievements in cancer research and cancer-related biomedical science.
Only individuals whose work has had a significant and long-lasting impact on the field are eligible for election as AACR Fellows. Annually, 11 individuals are chosen to join the AACR Academy, in honor of the 11 scientists and physicians who founded the AACR in 1907. These newly elected Fellows, upon joining the brain trust of global leaders in cancer research who are already in the AACR Academy, provide expert insight and guidance to the AACR as the organization continues to pursue its mission to prevent and cure all cancers.
“The amazing scientific contributions made by this year’s 11 Fellows have not only revolutionized cancer science, but have also provided the scientific foundation for countless other cancer professionals. The collective and exponential impact of their discoveries continues to be felt daily throughout the cancer field,” said Margaret Foti, PhD, MD (hc), chief executive officer of the AACR.
In addition to Cech, members of the 2016 class of Fellows of the AACR Academy are:
- Bruce M. Alberts, PhD, Chancellor’s Leadership Chair in Biochemistry and Biophysics for Science and Education, University of California, San Francisco, California;
- Clara D. Bloomfield, MD, distinguished university professor; William G. Pace III professor of cancer research; cancer scholar and senior advisor, The Ohio State University Comprehensive Cancer Center, James Cancer Hospital and Solove Research Institute, Columbus, Ohio;
- John E. Dick, PhD, Canada Research Chair in Stem Cell Biology and senior scientist, Princess Margaret Cancer Centre and McEwen Centre for Regenerative Medicine, University Health Network; professor, Department of Molecular Genetics, University of Toronto; director, Program in Cancer Stem Cells, Ontario Institute for Cancer Research, Toronto, Canada;
- Joe W. Gray, PhD, Gordon Moore endowed chair, Department of Biomedical Engineering; director, Center for Spatial Systems Biomedicine; associate director for biophysical oncology, Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon;
- Rudolf Jaenisch, MD, founding member, Whitehead Institute for Biomedical Research; professor of biology, Massachusetts Institute of Technology, Cambridge, Massachusetts;
- Eric S. Lander, PhD, professor of biology and systems biology, Harvard Medical School; founding director, The Broad Institute of MIT and Harvard, Cambridge, Massachusetts;
- Sir David P. Lane, PhD, chief scientist, Agency for Science, Technology and Research (A*STAR), Singapore; scientific director, Ludwig Institute for Cancer Research, New York, New York;
- Henry T. Lynch, MD, Charles F. and Mary C. Heider endowed chair in cancer research; chairman, Department of Preventive Medicine, Creighton University School of Medicine, Omaha, Nebraska;
- Joan Massagué, PhD, director, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, New York; and
- Joseph Schlessinger, PhD, William H. Prusoff professor and chair of pharmacology, Department of Pharmacology, Yale School of Medicine, New Haven, Connecticut.
The AACR will formally induct its 2016 class of elected Fellows of the AACR Academy at the AACR Annual Meeting 2016, to be held in New Orleans, April 16-20.